CytImmune Sciences Inc - Company & Market Research Reports

CytImmune Sciences, Inc. operates as a clinical stage nanomedicine company that discovers, develops, and commercializes multifunctional tumor-targeted therapies. The company develops Aurimune, a nanomedicine platform that gets into the tumor and breaks down its defenses. It is engineered to travel safely and stealthily through the body and enter tumors through their most vulnerable points – the leaky blood vessels that make up the nutritional support structures. CytImmune Sciences, Inc. was founded in 1988 and is based in Rockville, Maryland.

From
From
Thyroid Cancer - Pipeline Review, H2 2018 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H2 2018

  • Drug Pipelines
  • 604 Pages
From
From
Thyroid Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 567 Pages
From
From
From
Head And Neck Cancer - Pipeline Review, H2 2018 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2018

  • Drug Pipelines
  • 2001 Pages
From
Head And Neck Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1639 Pages
From
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2509 Pages
From
From
From
From
  • 18 Results (Page 1 of 1)
Loading Indicator
adroll